BBA
ASMB icon

Baker Bros. Advisors’s Assembly Biosciences ASMB Stock Holding History

Baker Bros. Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-175,718
Closed -$8.18M – 125
2021
Q2 		$8.18M Buy
175,718
+47,266
+37% +$2.34M 0.04% 82
2021
Q1 		$7.09M Hold
128,452
– – 0.03% 84
2020
Q4 		$9.33M Hold
128,452
– – 0.04% 76
2020
Q3 		$25.3M Sell
128,452
-16
-0% -$4.03K 0.1% 45
2020
Q2 		$36M Hold
128,468
– – 0.16% 37
2020
Q1 		$22.9M Hold
128,468
– – 0.14% 39
2019
Q4 		$31.5M Buy
128,468
+61,531
+92% +$11.3M 0.17% 39
2019
Q3 		$7.9M Hold
66,937
– – 0.05% 53
2019
Q2 		$10.8M Buy
66,937
+54,555
+441% +$10.4M 0.07% 50
2019
Q1 		$2.93M Hold
12,382
– – 0.02% 73
2018
Q4 		$3.36M Hold
12,382
– – 0.03% 62
2018
Q3 		$5.52M Hold
12,382
– – 0.04% 68
2018
Q2 		$5.83M Sell
12,382
-3,767
-23% -$1.99M 0.04% 69
2018
Q1 		$9.52M Sell
16,149
-10,745
-40% -$6.66M 0.08% 59
2017
Q4 		$14.6M Buy
26,894
+6,061
+29% +$2.74M 0.13% 53
2017
Q3 		$8.73M Hold
20,833
– – 0.07% 55
2017
Q2 		$5.16M Hold
20,833
– – 0.05% 64
2017
Q1 		$6.37M Hold
20,833
– – 0.05% 60
2016
Q4 		$3.04M Hold
20,833
– – 0.03% 75
2016
Q3 		$1.8M Hold
20,833
– – 0.02% 98
2016
Q2 		$1.39M Hold
20,833
– – 0.01% 108
2016
Q1 		$1.25M Hold
20,833
– – 0.01% 113
2015
Q4 		$1.88M Hold
20,833
– – 0.02% 108
2015
Q3 		$2.39M Hold
20,833
– – 0.02% 99
2015
Q2 		$4.82M Hold
20,833
– – 0.04% 81
2015
Q1 		$3.31M Buy
+20,833
New +$2.82M 0.03% 89
2014
Q2 		– Sell
-6,962
Closed -$535K – 106
2014
Q1 		$535K Sell
6,962
-13,302
-66% -$2.07M 0.01% 103
2013
Q4 		$4.64M Hold
20,264
– – 0.07% 67
2013
Q3 		$3.51M Hold
20,264
– – 0.05% 62
2013
Q2 		$2.92M Buy
+20,264
New +$3.18M 0.06% 58

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Baker Bros. Advisors's ASMB Position: Q3 2021 in Review

Baker Bros. Advisors sold out of Assembly Biosciences (ASMB) in Q3 2021, closing a stake of 175,718 shares — an estimated $8.18M sold.

Baker Bros. Advisors first reported a position in ASMB in Q2 2013 and held it in 30 quarters. The position peaked at $36M in Q2 2020. 65 funds tracked by Wall St. Rank hold ASMB as of Q3 2021.

  • Baker Bros. Advisors reported no remaining Assembly Biosciences position as of Q3 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 175,718 Assembly Biosciences shares in Q3 2021, an estimated $8.18M.
  • Baker Bros. Advisors first reported a position in Assembly Biosciences in Q2 2013 and held it in 30 quarters.
  • Baker Bros. Advisors's Assembly Biosciences position peaked at $36M in Q2 2020.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2021.

Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.